Familial partial lipodystrophy type 1. A rare or underdiagnosed syndrome?

被引:0
作者
Soutelo, Jimena [1 ]
Grueneisen, Mariana [1 ]
Fritz, Clara [1 ]
Sordo, Laura [1 ]
Powazniak, Yanina [2 ]
Lutfi, Ruben [1 ]
机构
[1] Complejo Med Churruca Visca, Serv Endocrinol, RA-1437 Buenos Aires, DF, Argentina
[2] Argenomics SA, Buenos Aires, DF, Argentina
关键词
familial partial lipodystrophy; Kobberling syndrome; DUNNIGAN VARIETY; MUTATION; GENE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial partial lipodystrophy ( FPL) type 1 is a syndrome characterized by loss of subcutaneous fat in arms and legs and an excess of body fat in face, neck, and torso. This rare syndrome is usually diagnosed when patients present cardiovascular complications or pancreatitis due to the severe metabolic abnormalities. Here we present the case of a 45 year old diabetic female without any pathological family history, a poor glycemic control ( HbA1c 11.7%), hypertriglideridemia ( 3000 mg/ dl), a body mass index ( BMI) of 38, thin limbs, subcutaneous fat loss in gluteal area and ledge of fat above them, prominent veins in lower extremities, moon face, and acanthosis nigricans; as well as hypertension ( 150/ 100 mmHg) and subcutaneous folds measuring less than average were observed. Hypercortisolism was discarded and leptin levels were measured ( 16.8 mg/ ml, VR: BMI > 30: 50 mg/ ml). Due to these clinical and biochemical manifestations, and low leptin levels ( 16.8 mg/ ml), Kobberling syndrome was suspected; however, LMNA mutation analysis was negative. Changes in lifestyle and treatment with fenofibrate, biphasic insulin 50/ 50, and enalapril were initiated showing a a significant metabolic improvement: HbA1c ( 7.8%) and TG ( 243 mg/ dl). FPL type 1 is a familial disease, although there are spontaneous cases. No specific mutation is responsible for this syndrome. Due to its clinical manifestations, Cushing syndrome must be discarded.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 13 条
  • [1] A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy
    Agarwal, AK
    Garg, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) : 408 - 411
  • [2] CLINICAL EFFECTS OF LONG-TERM METRELEPTIN TREATMENT IN PATIENTS WITH LIPODYSTROPHY
    Chan, Jean L.
    Lutz, Karen
    Cochran, Elaine
    Huang, Wenying
    Peters, Yvette
    Weyer, Christian
    Gorden, Phillip
    [J]. ENDOCRINE PRACTICE, 2011, 17 (06) : 922 - 932
  • [3] Metreleptin: First Global Approval
    Chou, Ken
    Perry, Caroline M.
    [J]. DRUGS, 2013, 73 (09) : 989 - 997
  • [4] Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy
    Gandotra, Sheetal
    Le Dour, Caroline
    Bottomley, William
    Cervera, Pascale
    Giral, Philippe
    Reznik, Yves
    Charpentier, Guillaume
    Auclair, Martine
    Delepine, Marc
    Barroso, Ines
    Semple, Robert K.
    Lathrop, Mark
    Lascols, Olivier
    Capeau, Jacqueline
    O'Rahilly, Stephen
    Magre, Jocelyne
    Savage, David B.
    Vigouroux, Corinne
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (08) : 740 - 748
  • [5] Lipodystrophies: Genetic and Acquired Body Fat Disorders
    Garg, Abhimanyu
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (11) : 3313 - 3325
  • [6] Lipodystrophies: Disorders of adipose tissue biology
    Garg, Abhimanyu
    Agarwal, Anil K.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (06): : 507 - 513
  • [7] A family with severe insulin resistance and diabetes due to a mutation in AKT2
    George, S
    Rochford, JJ
    Wolfrum, C
    Gray, SL
    Schinner, S
    Wilson, JC
    Soos, MA
    Murgatroyd, PR
    Williams, RM
    Acerini, CL
    Dunger, DB
    Barford, D
    Umpleby, AM
    Wareham, NJ
    Davies, HA
    Schafer, AJ
    Stoffel, M
    O'Rahilly, S
    Barroso, I
    [J]. SCIENCE, 2004, 304 (5675) : 1325 - 1328
  • [8] THE CLINICAL APPROACH TO THE DETECTION OF LIPODYSTROPHY - AN AACE CONSENSUS STATEMENT
    Handelsman, Yehuda
    Oral, Elif A.
    Bloomgarden, Zachary T.
    Brown, Rebecca J.
    Chan, Jean L.
    Einhorn, Daniel
    Garber, Alan J.
    Garg, Abhimanyu
    Garvey, W. Timothy
    Grunberger, George
    Henry, Robert R.
    Lavin, Norman
    Tapiador, Carmen D.
    Weyer, Christian
    [J]. ENDOCRINE PRACTICE, 2013, 19 (01) : 107 - 116
  • [9] Kobberling type of familial partial lipodystrophy - An underrecognized syndrome
    Herbst, KL
    Tannock, LR
    Deeb, SS
    Purnell, JQ
    Brunzell, JD
    Chait, A
    [J]. DIABETES CARE, 2003, 26 (06) : 1819 - 1824
  • [10] Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22
    Peters, JM
    Barnes, R
    Bennett, L
    Gitomer, WM
    Bowcock, AM
    Garg, A
    [J]. NATURE GENETICS, 1998, 18 (03) : 292 - 295